Literature DB >> 25361748

Thyroid eye disease: a Southeast Asian experience.

Nigel C S Lim1, Gangadhara Sundar2, Shantha Amrith2, Kok Onn Lee3.   

Abstract

AIM: To study the demographics, comorbidities, clinical manifestations and treatment methods of thyroid eye disease (TED) in Singapore.
METHODS: In this retrospective case series, we analysed the case records of all patients with TED who presented at our multidisciplinary Thyroid Eye Clinic from November 2002 to October 2012.
RESULTS: There were a total of 174 patients-111 female patients (63.8%) and 63 male patients (36.2%). The majority of the patients were ethnically Chinese (80.5%), followed by Malay (10.3%) and Indian (6.3%). The mean age was 40.2 years (SD±15.5, range 0.3-87.0). The commonest sign on ophthalmic examination was eyelid retraction (62.1%), followed by proptosis (61.0%) and lid lag (57.5). Acquired epiblepharon and corneal erosions were noted in 11.5% and 29.3% respectively. Eight patients (4.6%) had dysthyroid optic neuropathy. The mean exophthalmometry reading was 18.8 mm (SD±3.32, range 10.0-28.0). Mild, moderate and severe disease was noted in 71.3%, 20.7% and 8.0% respectively. Thyroid dysfunction was managed with anti-thyroid medication only (40.2%), β blockers (19.5%), thyroxine replacement (14.4%), radioactive iodine (14.4%) and block-replace regime (9.8%). Clinically significant active orbitopathy was managed with intravenous corticosteroids (12.1%). Surgical procedures consisted of thyroidectomy (10.3%), eyelid surgery (8.6%), orbital decompression (7.5%), epiblepharon correction (2.3%) and strabismus surgery (0.6%).
CONCLUSIONS: Corneal erosion secondary to acquired epiblepharon is a common sign in East Asian patients with TED, thus increased awareness among physicians should be encouraged. Mean exophthalmometry values and frequencies of upper eyelid retraction and oedema are lower in East Asian patients compared with Caucasian patients. Among Singapore's multi-ethnic population, Malay patients with TED had the highest exophthalmometry reading. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Orbit

Mesh:

Substances:

Year:  2014        PMID: 25361748     DOI: 10.1136/bjophthalmol-2014-305649

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases.

Authors:  Qian Li; Huijing Ye; Yungang Ding; Guo Chen; Zhichang Liu; Jianan Xu; Rongxin Chen; Huasheng Yang
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

2.  Evaluation of Neutrophil-to-Lymphocyte Ratio and Mean Platelet Volume in Patients with Active and Inactive Thyroid Orbitopathy.

Authors:  Cemile Üçgül Atılgan; Selam Yekta Şendül; Pınar Kösekahya; Mehtap Çağlayan; Alpaslan Alkan; Dilek Güven; Pelin Yılmazbaş
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2018-03-21

3.  Thyroid Eye Disease-Related Epiblepharon: A Comparative Case Study.

Authors:  Jiawei Zhao; Nickisa M Hodgson; Jessica R Chang; Ashley A Campbell; Timothy J McCulley
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 Jan-Feb

4.  Clinical profile of thyroid eye disease and factors predictive of disease severity.

Authors:  Alankrita Muralidhar; Sima Das; Sweety Tiple
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

5.  Visual morbidity in thyroid eye disease in Asian Indian patients.

Authors:  Roshmi Gupta; Rwituja Thomas; Fatema Almukhtar; Anjali Kiran
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

6.  Commentary: Thyroid eye disease-does the profile differ in India?

Authors:  Ashok Kumar Grover
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

7.  Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves' disease.

Authors:  Huiling Liew; Torquil Watt; Luo Nan; Alvin W K Tan; Yiong Huak Chan; Daniel Ek Kwang Chew; Rinkoo Dalan
Journal:  J Patient Rep Outcomes       Date:  2021-07-08

8.  Severe Ophthalmological Complications of Thyroid Disease are Rare in Ibadan, Southwestern Nigeria: Results of a Pilot Study.

Authors:  Olufunmilola A Ogun; Jokotade O Adeleye
Journal:  Ophthalmol Eye Dis       Date:  2016-03-28

9.  Bovine Acellular Dermal Matrix for Levator Lengthening in Thyroid-Related Upper-Eyelid Retraction.

Authors:  Jing Sun; Xingtong Liu; Yidan Zhang; Yazhuo Huang; Sisi Zhong; Sijie Fang; Ai Zhuang; Yinwei Li; Huifang Zhou; Xianqun Fan
Journal:  Med Sci Monit       Date:  2018-05-02

Review 10.  Management of Thyroid Eye Disease-Related Strabismus.

Authors:  Mohammad Reza Akbari; Arash Mirmohammadsadeghi; Raziyeh Mahmoudzadeh; Amirreza Veisi
Journal:  J Curr Ophthalmol       Date:  2020-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.